Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marksans Pharma has over 300 generic products across 10+ therapeutic areas with a strong focus on OTC and prescription solid oral dosage forms. The company has more than 50 FDA-approved products in the US market and over 100 in the UK under its Bells Healthcare brand. It continues to expand its pipeline with new product launches in regulated markets such as the US and UK. Recent approvals include fluoxetine capsules for depression/mood disorders and levonorgestrel tablets for emergency contraception.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marksans Pharma.